Atorvastatin efficacy in the primary and secondary prevention of cardiovascular events
M Arca, A Gaspardone - Drugs, 2007 - Springer
Atorvastatin has been extensively studied in the primary and secondary prevention of
cardiovascular events, and may have some clinical advantages over various other statins in …
cardiovascular events, and may have some clinical advantages over various other statins in …
Atorvastatin Efficacy in the Primary and Secondary Prevention of Cardiovascular Events.
M Arca, A Gaspardone - Drugs, 2007 - search.ebscohost.com
Atorvastatin has been extensively studied in the primary and secondary prevention of
cardiovascular events, and may have some clinical advantages over various other statins in …
cardiovascular events, and may have some clinical advantages over various other statins in …
Atorvastatin efficacy in the primary and secondary prevention of cardiovascular events.
M Arca, G Achille - DRUGS, 2007 - iris.uniroma1.it
Atorvastatin has been extensively studied in the primary and secondary prevention of
cardiovascular events, and may have some clinical advantages over various other statins in …
cardiovascular events, and may have some clinical advantages over various other statins in …
Atorvastatin efficacy in the primary and secondary prevention of cardiovascular events.
M Arca, A Gaspardone - Drugs, 2007 - europepmc.org
Atorvastatin has been extensively studied in the primary and secondary prevention of
cardiovascular events, and may have some clinical advantages over various other statins in …
cardiovascular events, and may have some clinical advantages over various other statins in …
Atorvastatin efficacy in the primary and secondary prevention of cardiovascular events
M Arca, A Gaspardone - Drugs, 2007 - hero.epa.gov
Atorvastatin has been extensively studied in the primary and secondary prevention of
cardiovascular events, and may have some clinical advantages over various other statins in …
cardiovascular events, and may have some clinical advantages over various other statins in …
[引用][C] Atorvastatin Efficacy in the Primary and Secondary Prevention of Cardiovascular Events
M Arca, A Gaspardone - Drugs, 2007 - cir.nii.ac.jp
Atorvastatin Efficacy in the Primary and Secondary Prevention of Cardiovascular Events | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Atorvastatin efficacy in the primary and secondary prevention of cardiovascular events
M Arca, A Gaspardone - Drugs, 2007 - pubmed.ncbi.nlm.nih.gov
Atorvastatin has been extensively studied in the primary and secondary prevention of
cardiovascular events, and may have some clinical advantages over various other statins in …
cardiovascular events, and may have some clinical advantages over various other statins in …
[引用][C] Atorvastatin Efficacy in the Primary and Secondary Prevention of Cardiovascular Events
M ARCA, A GASPARDONE - Drugs (Basel), 2007 - pascal-francis.inist.fr
Atorvastatin Efficacy in the Primary and Secondary Prevention of Cardiovascular Events CNRS
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …